HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhihong Chen Selected Research

Ligands

1/2022Inhibition of CCCTC Binding Factor-Programmed Cell Death Ligand 1 Axis Suppresses Emergence of Chemoresistance Induced by Gastric Cancer-Derived Mesenchymal Stem Cells.
1/2020Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis.
12/2019Tumour-associated macrophage-derived interleukin-1 mediates glioblastoma-associated cerebral oedema.
1/2007NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhihong Chen Research Topics

Disease

73Neoplasms (Cancer)
03/2024 - 03/2002
18Inflammation (Inflammations)
02/2024 - 06/2005
12Hepatocellular Carcinoma (Hepatoma)
04/2023 - 08/2020
11Asthma (Bronchial Asthma)
03/2024 - 09/2016
8Neoplasm Metastasis (Metastasis)
03/2024 - 05/2009
8Lung Neoplasms (Lung Cancer)
12/2023 - 06/2010
7Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
02/2024 - 03/2018
7Stomach Neoplasms (Stomach Cancer)
01/2024 - 01/2018
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 12/2007
6Adenocarcinoma of Lung
10/2023 - 04/2006
6Chronic Obstructive Pulmonary Disease (COPD)
01/2023 - 05/2010
6Infections
01/2022 - 03/2002
5Breast Neoplasms (Breast Cancer)
01/2024 - 03/2002
5Type 2 Diabetes Mellitus (MODY)
12/2020 - 01/2012
4Demyelinating Diseases (Demyelinating Disease)
02/2024 - 05/2013
4Carcinoma (Carcinomatosis)
03/2023 - 12/2007
4Epilepsy (Aura)
01/2023 - 02/2014
4Acute Lung Injury
01/2022 - 12/2017
4Multiple Sclerosis
02/2015 - 01/2007
3Disease Progression
02/2024 - 04/2015
3Traumatic Brain Injuries (Traumatic Brain Injury)
01/2024 - 01/2023
3Autoimmune Diseases (Autoimmune Disease)
12/2023 - 04/2015
3Diabetes Mellitus
12/2023 - 01/2012
3Hypoxia (Hypoxemia)
01/2023 - 04/2004
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2022 - 10/2017
3Pneumonia (Pneumonitis)
01/2022 - 06/2011
3Glioma (Gliomas)
12/2021 - 01/2018
3Infarction (Infarctions)
09/2021 - 08/2013
3Glioblastoma (Glioblastoma Multiforme)
12/2019 - 01/2018
3Melanoma (Melanoma, Malignant)
04/2014 - 05/2009
2Pain (Aches)
02/2024 - 09/2002
2Periodontitis
11/2023 - 12/2015
2Squamous Cell Carcinoma of Head and Neck
08/2023 - 01/2022
2Genomic Instability
02/2023 - 08/2006
2Leukemia
06/2021 - 10/2005
2Fibrosis (Cirrhosis)
01/2021 - 10/2017
2Colonic Neoplasms (Colon Cancer)
01/2020 - 12/2015
2Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 12/2015

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
02/2024 - 05/2011
12Biomarkers (Surrogate Marker)IBA
03/2024 - 04/2015
9CytokinesIBA
03/2024 - 04/2015
8Small Interfering RNA (siRNA)IBA
08/2023 - 04/2006
8ErbB Receptors (EGF Receptor)IBA
04/2019 - 04/2006
7RNA (Ribonucleic Acid)IBA
01/2024 - 01/2017
7LipopolysaccharidesIBA
01/2022 - 05/2010
6Messenger RNA (mRNA)IBA
03/2024 - 07/2002
6Sericins (Sericin)IBA
01/2021 - 01/2012
4Interleukin-6 (Interleukin 6)IBA
12/2023 - 04/2015
4Long Noncoding RNAIBA
10/2023 - 01/2020
4HydrogelsIBA
04/2023 - 01/2022
4ibrutinibIBA
01/2023 - 08/2017
4MicroRNAs (MicroRNA)IBA
10/2022 - 11/2014
4Insulin (Novolin)FDA Link
08/2022 - 10/2017
4OvalbuminIBA
01/2022 - 01/2019
4LigandsIBA
01/2022 - 01/2007
4Tyrosine Kinase InhibitorsIBA
01/2022 - 12/2007
4p38 Mitogen-Activated Protein KinasesIBA
02/2020 - 06/2010
4AntigensIBA
03/2018 - 10/2005
3Adrenal Cortex Hormones (Corticosteroids)IBA
03/2024 - 01/2019
3Agammaglobulinaemia Tyrosine KinaseIBA
02/2024 - 01/2023
3Therapeutic UsesIBA
11/2023 - 12/2019
3Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
11/2023 - 12/2019
3LipidsIBA
11/2023 - 03/2002
34,4'-hexafluorisopropylidene diphenolIBA
04/2022 - 09/2021
3GlucocorticoidsIBA
02/2020 - 11/2016
3Gefitinib (Iressa)FDA Link
04/2019 - 12/2007
3Streptozocin (Streptozotocin)FDA Link
07/2013 - 01/2012
3MucinsIBA
06/2011 - 05/2010
3Aquaporin 5IBA
06/2011 - 05/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2023 - 08/2023
2Monocyte Chemoattractant ProteinsIBA
11/2023 - 06/2015
2oxidized low density lipoproteinIBA
11/2023 - 12/2015
2LDL Lipoproteins (beta Lipoproteins)IBA
11/2023 - 12/2015
2AntioxidantsIBA
08/2023 - 10/2017
2Reactive Oxygen Species (Oxygen Radicals)IBA
08/2023 - 10/2017
2InterleukinsIBA
04/2023 - 04/2015
2lenvatinibIBA
01/2023 - 01/2023
21-aminobenzotriazoleIBA
01/2023 - 09/2021
2Immune Checkpoint InhibitorsIBA
01/2023 - 01/2022
2prednylidene (Pred)IBA
01/2023 - 01/2022
2Rituximab (Mabthera)FDA Link
11/2022 - 08/2008
2venetoclaxIBA
11/2022 - 01/2022
2Glucose (Dextrose)FDA LinkGeneric
10/2022 - 02/2014
2Ethanol (Ethyl Alcohol)IBA
03/2022 - 12/2015
2Proteoglycans (Proteoglycan)IBA
01/2022 - 05/2009
2Interleukin-4 (Interleukin 4)IBA
01/2022 - 09/2016
2Substance PIBA
01/2021 - 01/2017
2Immune Checkpoint ProteinsIBA
10/2020 - 01/2018
2Interleukin-8 (Interleukin 8)IBA
01/2020 - 11/2018
2CateninsIBA
01/2020 - 12/2015

Therapy/Procedure

37Therapeutics
03/2024 - 11/2011
14Immunotherapy
01/2024 - 06/2015
7Drug Therapy (Chemotherapy)
01/2024 - 01/2020
4Injections
08/2022 - 01/2016
4Radiotherapy
02/2021 - 01/2019
3Transplantation
03/2024 - 01/2021
3Deep Brain Stimulation
01/2023 - 07/2014
2Lasers (Laser)
03/2023 - 04/2019
2Neoadjuvant Therapy
01/2023 - 05/2015
2Glycemic Control
01/2022 - 01/2021